Clinical-stage pharma for cancer cachexia
| Date | Round | Amount |
|---|---|---|
| Jan 2023 | Seed Actimed Therapeutics, a UK specialty pharma, raised a GBP5M final seed tranche led by Mankind Pharma. | $6.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.